Elevation of high-mobility group box 1 concentration in asphyxiated neonates

Neonatology

Volumn 94, Issue 2, 2008, Pages 105-109

  Okazaki, Kaoru ^a   Kondo, Masatoshi ^a   Kato, Masahiko ^c   Kakinuma, Ryota ^a   Nishida, Akira ^a   Noda, Masahiro ^b   Kimura, Hirokazu ^b  

^a Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

Asphyxia; High mobility group box 1 (HMGB 1); Inflammation; Neonates

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN HYPOXIA; PRIORITY JOURNAL;

APGAR SCORE; ASPHYXIA NEONATORUM; BIRTH WEIGHT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HMGB1 PROTEIN; HUMANS; INFANT, NEWBORN;

EID: 49449106963     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000116635     Document Type: Article

References (31)

1. Volpe JJ: Hypoxic-ischemic encephalopathy; in Volpe JJ (ed): Neurology of the Newborn, ed 4. Philadelphia, Saunders, 2001, pp 217-394.
2. Kondo M, Itoh S, Isobe K, Kondo M, Kunikata T, Imai T, Onishi S: Chemiluminescence because of the production of reactive oxygen species in the lungs of newborn piglets during resuscitation periods after asphyxiation load. Pediatr Res 2000;47:524-527.
3. Hammerman C, Kaplan M: Ischemia and reperfusion injury: the ultimate pathophysiologic paradox. Clin Perinatol 1998;25:757-777.
4. Loddick SA, Rothwell NJ: Cytokines and neurodegeneration;in Rothwell NJ, Loddick SA (eds): Immune and Inflammatory Responses in the Nervous System, ed 2. Oxford, Oxford University Press, 2002, pp 90-105.
5. Goodwin GH, Sanders C, Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973;38:14-19.
6. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-5246.
7. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB1: guiding immunity from within. Trends Immunol 2005;26:381-387.
8. Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004;255:320-331.
9. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
10. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ: HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001;164:1768-1773.
11. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000;165:2950-2954.
12. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-2660.
13. Tsung A, Zheng N, Jeyabalan G, Izuishi K, Klune JR, Geller DA, Lotze MT, Lu L, Billiar TR: Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 2001;81:119-128.
14. Phelan JP, Martin GI, Korst LM: Birth asphyxia and cerebral palsy. Clin Perinatol 2005;32:61-76.
15. Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, Pacifico L: Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003;33:352-358.
16. Okazaki K, Nishida A, Kato M, Kozawa K, Uga N, Kimura H: Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate 2006;89:183-189.
17. Noetzel MJ: Perinatal trauma and cerebral palsy. Clin Perinatol 2006;33:355-366.
18. Shalak LF, Laptook AR, Jafri HS, Ramilo O, Perlman JM: Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002;110:673-680.
19. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I: New high mobility group box 1 assay system. Clin Chim Acta 2006;372:173-178.
20. Fellman V, Raivio KO: Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997;41:599-606.
21. Hashimoto M, Nishida A, Minakami H, Takashima Y, Kato M, Okada Y, Ogawa Y, Itoh S, Kimura H: Decreased expression of L-selectin on peripheral blood polymorphonuclear leukocytes in neonates with severe asphyxia. Biol Neonate 2002;81:95-98.
22. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, Holst M, McRae A, Soder O: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-609.
23. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, Schmidt AM: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-25761.
24. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919-19924.
25. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP: The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507-1515.
26. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-570.
27. Xanthou M, Fotopoulos S, Mouchtouri A, Lipsou N, Zika I, Sarafidou J: Inflammatory mediators in perinatal asphyxia and infection. Acta Paediatr Suppl 2002;91:92-97.
28. Oygür N, Sönmez O, Saka O, Yeǧin O: Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998;79:F190-F193.
29. Silveira RC, Procianoy RS: Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003;143:625-629.
30. Ng PC: Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004;89:F229-F235.
31. Thorngren-Jerneck K, Alling C, Herbst A, Amer-Wahlin I, Marsal K: S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2004;55:406-412.